Skip to Content
Jump to the top of the page

Showing 510 – 520 of 1158 results

  • Hydrofarm Holdings Group Inc Initiation

    William Blair & Company initiated research coverage of Hydrofarm Holdings Group, Inc. (HYFM $50.43). Hydrofarm is a leading branded hydroponics company with innovative product solutions and a comprehensive distribution platform serving the controlled environment agriculture (CEA) market.

  • SOC Telemed Inc Initiation

    William Blair & Company initiated research coverage of SOC Telemed, Inc. (TLMD $8.15), one of the industry’s largest providers of telehealth solutions for the acute-care marketplace. The company focuses on three primary specialties, teleneurology, telepsychiatry, and teleICU, and has partnerships with approximately 850 facilities across the United States, including 18 of the top 25 acute-care chains in the country.

  • Biodesix Inc Initiation

    William Blair & Company initiated research coverage of Biodesix, Inc. (BDSX $16.06), a diagnostic company focused on development and commercialization of tests used in risk stratification for lung nodules and to aid in the treatment for lung cancer patients.

  • Translate Bio, Inc. Initiation

    William Blair & Company initiated research coverage of Translate Bio, Inc. (TBIO $17.45), a clinical-stage biopharmaceutical company focused on developing its proprietary mRNA therapeutic platform (MRT) to treat disorders with unmet need.

  • Oak Street Health Inc Initiation

    William Blair & Company initiated research coverage of Oak Street Health, Inc. (OSH $44.56), a fast-growing network of value-based primary care centers for adults on Medicare.

  • Lyra Therapeutics Inc Initiation

    William Blair & Company initiated research coverage of Lyra Therapeutics, Inc. (LYRA $14.90), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the treatment of patients with ear, nose, and throat (ENT) diseases.

  • Lemonade Inc Initiation

    William Blair & Company initiated research coverage of Lemonade, Inc. (LMND $82.16), a digital-first insurance provider, offering both homeowners and renters insurance domestically and internationally.

  • Acutus Medical Inc Initiation

    William Blair & Company initiated research coverage of Acutus Medical, Inc. (AFIB $30.96), a medical device company with a novel non-contact mapping technology for cardiac ablation and a broad portfolio of electrophysiology tools.

  • Alkami Technology Inc Initiation

    William Blair initiated research coverage of Alkami Technology, Inc. (ALKT $41.93). Alkami provides a cloud-based digital banking platform, primarily for credit unions and banks, that helps financial institutions embrace digital transformation.

  • Sumo Logic Inc Initiation

    William Blair & Company initiated research coverage of Sumo Logic, Inc. (SUMO $24.20). Sumo Logic is a next-generation provider of observability, monitoring, and security solutions through its Continuous Intelligence Platform.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures